COVID-19 in patients with blood cancer: a snapshot. ∗In post hoc analysis. ∗∗Among high-risk patients. Ab, antibody; CAR-T, chimeric antibody T-cell therapy; CLL, chronic lymphocytic leukemia; hosp, hospitalization; HR, hazard ratio; Ig, immunoglobulin; pts, patients; SCT, stem cell transplant.